Albireo Pharma Depreciation & Amortization 2011-2026 | ALBO

Annual Depreciation & Amortization Albireo Pharma

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
274 K	192 K	127 K	45 K	35 K	14 K	15 K	603 K	641 K	725 K	938 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
938 K	14 K	328 K

Quarterly Depreciation & Amortization Albireo Pharma

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	322 K	198 K	114 K	-	167 K	75 K	37 K	-	119 K	77 K	39 K	-	89 K	50 K	11 K	-	33 K	22 K	53 K	-	23 K	13 K	5 K	-	11 K	7 K	4 K	30 K	211 K	164 K	-	102 K	462 K	310 K	102 K	156 K	484 K	326 K	156 K	167 K	555 K	382 K	167 K	194 K	732 K	502 K	194 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
732 K	4 K	172 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Cabaletta Bio CABA	1.65 M	$ 3.4	4.29 %	$ 342 M	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Alnylam Pharmaceuticals ALNY	55.7 M	$ 333.39	-1.77 %	$ 43.7 B	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 3.17	3.93 %	$ 5.22 M	Israel
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Esperion Therapeutics ESPR	105 K	$ 2.17	5.85 %	$ 451 M	USA
Aligos Therapeutics ALGS	930 K	$ 7.42	-15.1 %	$ 73.3 M	USA
Forte Biosciences FBRX	64 K	$ 31.28	-3.52 %	$ 405 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
GT Biopharma GTBP	4 K	$ 0.39	-0.26 %	$ 2.15 M	USA
Amphastar Pharmaceuticals AMPH	31.6 M	$ 21.68	1.4 %	$ 1.01 B	USA
Harmony Biosciences Holdings HRMY	23.8 M	$ 29.22	-0.24 %	$ 1.68 B	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
ImmuCell Corporation ICCC	2.78 M	$ 7.6	-1.68 %	$ 68.6 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	1.27 M	$ 1.55	-0.64 %	$ 399 M	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Incyte Corporation INCY	93.3 M	$ 97.1	-0.6 %	$ 19 B	USA
Aquestive Therapeutics AQST	548 K	$ 4.24	2.17 %	$ 453 M	USA
Arcutis Biotherapeutics ARQT	700 K	$ 24.58	-2.03 %	$ 3.13 B	USA
Brainstorm Cell Therapeutics BCLI	199 K	-	-2.5 %	$ 5.88 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
Autolus Therapeutics plc AUTL	8.3 M	$ 1.49	0.68 %	$ 397 M	Britain
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA